130 related articles for article (PubMed ID: 12814505)
21. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
22. Methadone-related deaths among youth and young adults in Sweden 2006-15.
Fugelstad A; Bremberg S; Hjelmström P; Thiblin I
Addiction; 2021 Feb; 116(2):319-327. PubMed ID: 32533568
[TBL] [Abstract][Full Text] [Related]
23. Methadone related deaths compared to all prescription related deaths.
Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM
Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639
[TBL] [Abstract][Full Text] [Related]
24. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia.
Paulozzi LJ; Logan JE; Hall AJ; McKinstry E; Kaplan JA; Crosby AE
Addiction; 2009 Sep; 104(9):1541-8. PubMed ID: 19686524
[TBL] [Abstract][Full Text] [Related]
25. The methadone epidemic: methadone-related deaths on the rise in Vermont.
Madden ME; Shapiro SL
Am J Forensic Med Pathol; 2011 Jun; 32(2):131-5. PubMed ID: 21030851
[TBL] [Abstract][Full Text] [Related]
26. Fatal poisoning in methadone and buprenorphine treated patients -- are there differences?
Soyka M; Penning R; Wittchen U
Pharmacopsychiatry; 2006 May; 39(3):85-7. PubMed ID: 16721696
[TBL] [Abstract][Full Text] [Related]
27. The effectiveness and safety of methadone maintenance.
Ward J; Mattick RP; Hall W; Darke S
Addiction; 1996 Nov; 91(11):1727-9. PubMed ID: 8972930
[No Abstract] [Full Text] [Related]
28. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
[TBL] [Abstract][Full Text] [Related]
29. Recent contact with health and social services by drug misusers in Glasgow who died of a fatal overdose in 1999.
Jones R; Gruer L; Gilchrist G; Seymour A; Black M; Oliver J
Addiction; 2002 Dec; 97(12):1517-22. PubMed ID: 12472635
[TBL] [Abstract][Full Text] [Related]
30. [Forensic medicine experiences with methadone substitution in the Geneva canton].
La Harpe R; Perret G; Deglon JJ
Arch Kriminol; 2000; 206(1-2):1-7. PubMed ID: 11006820
[TBL] [Abstract][Full Text] [Related]
31. Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service.
Buckley V; Razaghi A; Haber P
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):464-70. PubMed ID: 23550533
[TBL] [Abstract][Full Text] [Related]
32. Methadone prescribing under supervised consumption on premises: a Scottish clinician's perspective on prescribing practice.
Anthony GB; Matheson CI; Holland R; Bond C; Roberts K; Rae AM; Whitelaw E; Priyadarshi S
Drug Alcohol Rev; 2012 May; 31(3):342-7. PubMed ID: 21726308
[TBL] [Abstract][Full Text] [Related]
33. Methadone maintenance treatment can be provided in a primary care setting without increasing methadone-related mortality: the Sheffield experience 1997-2000.
Keen J; Oliver P; Mathers N
Br J Gen Pract; 2002 May; 52(478):387-9. PubMed ID: 12014536
[TBL] [Abstract][Full Text] [Related]
34. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy.
Weinrich M; Stuart M
JAMA; 2000 Mar; 283(10):1343-8. PubMed ID: 10714738
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study.
McCowan C; Kidd B; Fahey T
BMJ; 2009 Jun; 338():b2225. PubMed ID: 19535400
[TBL] [Abstract][Full Text] [Related]
36. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
37. Deaths of heroin addicts starting on a methadone maintenance programme.
Drummer OH; Syrjanen M; Opeskin K; Cordner S
Lancet; 1990 Jan; 335(8681):108. PubMed ID: 1967385
[No Abstract] [Full Text] [Related]
38. Deaths from drugs of abuse in Sheffield 1997-1999: what are the implications for GPs prescribing to heroin addicts?
Oliver P; Keen J; Mathers N
Fam Pract; 2002 Feb; 19(1):93-4. PubMed ID: 11818356
[TBL] [Abstract][Full Text] [Related]
39. [Morbidity and mortality related to methadone].
Nolla-Salas J; García-Villanueva M; Teijeira R; de la Torre R
Med Clin (Barc); 2003 Sep; 121(7):276-7. PubMed ID: 12975041
[No Abstract] [Full Text] [Related]
40. Fatal methadone and heroin overdoses: time trends in England and Wales.
Neeleman J; Farrell M
J Epidemiol Community Health; 1997 Aug; 51(4):435-7. PubMed ID: 9328553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
